Cruiser Capital Advisors’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Cruiser Capital Advisors’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,266	Closed	-$924	–	83
2022 Q4	$924	Hold	10,266	–	–	﹤0.01%	62
2022 Q3	$1K	Hold	10,266	–	–	﹤0.01%	67
2022 Q2	$2K	Hold	10,266	–	–	﹤0.01%	70
2022 Q1	$4K	Buy	+10,266	New	+$4.75K	﹤0.01%	74

Cruiser Capital Advisors's MSACW Position: Q1 2023 in Review

Cruiser Capital Advisors sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 10,266 shares — an estimated $924 sold.

Cruiser Capital Advisors first reported a position in MSACW in Q1 2022 and held it in 4 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Cruiser Capital Advisors reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Cruiser Capital Advisors sold 10,266 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $924.
Cruiser Capital Advisors first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q1 2022 and held it in 4 quarters.
Cruiser Capital Advisors's Medicus Sciences Acquisition Corp. Warrant position peaked at $4K in Q1 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Cruiser Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.